{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:01Z","timestamp":1791306721772,"version":"4.3.1"},"reference-count":57,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"vor","delay-in-days":2289,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective:<\/jats:italic> Human immunodeficiency virus (HIV) patients on antiretroviral regimens frequently develop a syndrome of abnormal fat distribution, insulin resistance, and dyslipidemia. This lipodystrophic syndrome has been most closely linked to the use of HIV protease inhibitors (PIs). Several mechanisms have been postulated to explain these adverse effects of PIs, based largely on studies of rodent adipocytes. Intriguingly, atazanavir, a newer PI equally effective against HIV, is associated with fewer signs of lipodystrophy. We hypothesized that the less deleterious clinical effects of atazanavir would be reflected in physiological differences observed in PI\u2010treated adipocytes.<\/jats:p><jats:p><jats:italic>Research Methods and Procedures:<\/jats:italic> We compared the effects of atazanavir and an older PI associated with lipodystrophy, ritonavir, on differentiation, gene expression, adipocytokine secretion, and insulin signaling in a human adipocyte cell line.<\/jats:p><jats:p><jats:italic>Results:<\/jats:italic> Ritonavir inhibited human adipocyte differentiation and induced apoptosis to a greater extent than atazanavir. Treatment of mature adipocytes with ritonavir, but not atazanavir, also selectively decreased insulin signaling. Moreover, ritonavir also selectively decreased expression of adiponectin, an insulin\u2010sensitizing adipocytokine, while inducing interleukin\u20106, a proinflammatory cytokine implicated in insulin resistance.<\/jats:p><jats:p><jats:italic>Discussion:<\/jats:italic> These data suggest that the distinct metabolic side effect profiles of these PIs could be a consequence of their differential effects on adipocyte physiology.<\/jats:p>","DOI":"10.1038\/oby.2006.114","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T14:10:32Z","timestamp":1208959832000},"page":"994-1002","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["HIV Protease Inhibitor\u2010Specific Alterations in Human Adipocyte Differentiation and Metabolism"],"prefix":"10.1002","volume":"14","author":[{"given":"Roy J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camella G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell A.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Steppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)77775-8"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11672-2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200402123500719"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80283-7"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200308010-00012"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-44709"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.6.1425"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00005"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000228200"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200204120-00005"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410826200"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.6.1378"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.4274"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(00)00102-9"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08094-7"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900412"},{"key":"e_1_2_7_18_2","author":"Sension M. G.","year":"2002","journal-title":"Absence of insulin resistance through week 24 with atazanavir once-daily and efavirenz once-daily each with fixed-dose zdovudine plus lamivudine. 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, San Diego, CA"},{"key":"e_1_2_7_19_2","volume-title":"11th Conference on Retroviruses and Opportunistic Infections","author":"Noor M.","year":"2004"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200404090-00016"},{"key":"e_1_2_7_21_2","first-page":"174","article-title":"Switching to atazanavir improves metabolic disorders in antiretroviral\u2010experienced patients with severe hyperlipidemia","volume":"39","author":"Mobius U.","year":"2005","journal-title":"J AIDS"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200312050-00007"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801520"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/00002030-199910220-00011","article-title":"The relationship between ritonavir plasma levels and side\u2010effects: implications for therapeutic drug monitoring","volume":"13","author":"Gatti G.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_7_26_2","volume-title":"Reyataz (Atazanavir Sulfate) Patient Information Leaflet","author":"Bristol\u2010Myers Squibb Co","year":"2005"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922203771881248"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1720155"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.010165"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5407.1544"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00006"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00011"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212150-00009"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020795"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021600"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301977200"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.10.013"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.3.7305"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00524-0"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411050-00005"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11518-5"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021922"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021600"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200069200"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200310170-00005"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200501010-00010"},{"key":"e_1_2_7_48_2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu C.","year":"2004","journal-title":"Antiviral Therap."},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1262"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2194"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.4.937"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1408-5"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408687200"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00004"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2004.12.007"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0005"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400373-JLR200"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.7.2003"}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Foby.2006.114","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/oby.2006.114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T08:21:17Z","timestamp":1698740477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1038\/oby.2006.114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1038\/oby.2006.114"],"URL":"https:\/\/doi.org\/10.1038\/oby.2006.114","archive":["Portico"],"relation":{},"ISSN":["1930-7381","1930-739X"],"issn-type":[{"value":"1930-7381","type":"print"},{"value":"1930-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"2012-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}